Clinical Trial Update: Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial assessing curcumin to prevent radiation-induced dermatitis in breast cancer patients. The study has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: University of Rochester | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-06-20